Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease
- 1 April 1985
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 55 (9) , 1204-1209
- https://doi.org/10.1016/0002-9149(85)90664-2
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental AnimalsJournal of Cardiovascular Pharmacology, 1983
- Characterization of the Cardiotonic Effects of Milrinone, a New and Potent Cardiac Bipyridine, on Isolated Tissues from Several Animal SpeciesJournal of Cardiovascular Pharmacology, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.Heart, 1983
- The contractile behavior of the heart and its functional coupling to the circulationProgress in Cardiovascular Diseases, 1982
- Physiologic and pharmacologic determinants of vasodilator response: A conceptual framework for rational drug therapy for chronic heart failurePublished by Elsevier ,1982
- Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].Circulation Research, 1979
- New cardiotonic agents: A search for digitalis substituteLife Sciences, 1978
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977